These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1336219)

  • 1. [Topical administration of unfractionated and low molecular weight heparin for prevention of appositional thrombus formation].
    Koppenhagen K; Häring R; Proksch W; Erdmann K; Leick M; Bundrock P; Franke J
    Vasa Suppl; 1992; 35():99-100. PubMed ID: 1336219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
    Marbet GA
    Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
    Weinand HA; Gehrke T; Krieg H; Brünner H
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1175-7. PubMed ID: 1983508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
    Breddin HK
    Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Hirsh J
    N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
    Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
    Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of low molecular weight heparin in combination with dihydroergotamine on experimental thrombosis and haemostasis.
    Bergqvist D; Nilsson B
    Thromb Haemost; 1987 Oct; 58(3):893-5. PubMed ID: 2829377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
    Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
    Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of thrombosis in minimally invasive surgery].
    Harenberg J
    Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
    Quenby S; Mountfield S; Cartwright JE; Whitley GS; Vince G
    Obstet Gynecol; 2004 Aug; 104(2):354-61. PubMed ID: 15292011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of clinical trials of low molecular weight heparin fractions.
    Levine MN; Hirsh J
    Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies].
    Koppenhagen K; Tröster E; Matthes M; Häring R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1163-6. PubMed ID: 1983504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.